Literature DB >> 9231652

Demonstration of two different processes of beta-cell regeneration in a new diabetic mouse model induced by selective perfusion of alloxan.

M Waguri1, K Yamamoto, J I Miyagawa, Y Tochino, K Yamamori, Y Kajimoto, H Nakajima, H Watada, I Yoshiuchi, N Itoh, A Imagawa, M Namba, M Kuwajima, Y Yamasaki, T Hanafusa, Y Matsuzawa.   

Abstract

To clarify the regeneration process of pancreatic beta-cells, we established a new mouse model of diabetes induced by selective perfusion of alloxan after clamping the superior mesenteric artery. In this model, diabetes could be induced by the destruction of beta-cells in alloxan-perfused segments, while beta-cells in nonperfused segments were spared. Intraperitoneal glucose tolerance tests showed glucose intolerance, which gradually ameliorated and was completely normalized in 1 year with a concomitant increase of insulin content in the pancreas. Histological examination showed neo-islet formation in the alloxan-perfused segment and the proliferation of spared beta-cells in the nonperfused segment. In the alloxan-perfused segment, despite a marked reduction of islets in size and number at an early stage, both the number of islets, including islet-like cell clusters (ICCs), and the relative islet area significantly increased at a later stage. Increased single beta-cells and ICCs were located in close contact with duct cell lining, suggesting that they differentiated from duct cells and that such extra-islet precursor cells may be important for beta-cell regeneration in beta-cell-depleted segment. In addition to beta-cells, some nonhormone cells in ICCs were positive for nuclear insulin promoter factor 1, which indicated that most, if not all, nonhormone cells positive for this factor were beta-cell precursors. In the nonperfused segment, the islet area increased significantly, and the highest 5-bromo-2-deoxyuridine-labeling index in beta-cells was observed at day 5, while the number of islets did not increase significantly. This indicated that the regeneration of islet endocrine cells occurs mostly through the proliferation of preexisting intra-islet beta-cells in the nonperfused segment. In conclusion, the regeneration process of beta-cells varied by circumstance. Our mouse model is useful for studying the mechanism of regeneration, since differentiation and proliferation could be analyzed separately in one pancreas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231652     DOI: 10.2337/diab.46.8.1281

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

1.  Bone marrow: an extra-pancreatic hideout for the elusive pancreatic stem cell?

Authors:  Vivian M Lee; Markus Stoffel
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

2.  Transcranial stimulation normalizes blood sugar levels in alloxan diabetes in rats.

Authors:  V P Lebedev; S V Bilichenko; A V Malygin; S P Nechiporenko; S E Kolbasov; M V Melikhova
Journal:  Neurosci Behav Physiol       Date:  2006-01

3.  Transcranial electrostimulation activates reparative regeneration and the insulin-producing function of pancreatic B-cells in alloxan diabetes in rats.

Authors:  V P Lebedev; S V Bilichenko; N E Ordyan; S G Pivina; S P Nechiporenko; A A Puzyrev; E A Mikheeva; K K Kubacheva
Journal:  Neurosci Behav Physiol       Date:  2007-05

4.  Pathogenesis of fulminant type 1 diabetes.

Authors:  Akihisa Imagawa; Toshiaki Hanafusa
Journal:  Rev Diabet Stud       Date:  2007-02-10

5.  Preserving Mafa expression in diabetic islet β-cells improves glycemic control in vivo.

Authors:  Taka-aki Matsuoka; Hideaki Kaneto; Satoshi Kawashima; Takeshi Miyatsuka; Yoshihiro Tochino; Atsushi Yoshikawa; Akihisa Imagawa; Jun-ichi Miyazaki; Maureen Gannon; Roland Stein; Iichiro Shimomura
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

Review 6.  Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.

Authors:  M Mimeault; S K Batra
Journal:  Gut       Date:  2008-10       Impact factor: 23.059

Review 7.  Islet neogenesis: a possible pathway for beta-cell replenishment.

Authors:  Susan Bonner-Weir; Lili Guo; Wan-Chun Li; Limor Ouziel-Yahalom; Philippe A Lysy; Gordon C Weir; Arun Sharma
Journal:  Rev Diabet Stud       Date:  2012-12-28

8.  Successful pharmaceutical-grade streptozotocin (STZ)-induced hyperglycemia in a conscious tethered baboon (Papio hamadryas) model.

Authors:  Patrice A Frost; Shuyuan Chen; Marguerite J Mezzles; Venkata Saroja Voruganti; Edna J Nava-Gonzalez; Hector E Arriaga-Cazares; Katy A Freed; Anthony G Comuzzie; Ralph A DeFronzo; Jack W Kent; Paul A Grayburn; Raul A Bastarrachea
Journal:  J Med Primatol       Date:  2015-06-30       Impact factor: 0.667

9.  Mechanisms of KGF mediated signaling in pancreatic duct cell proliferation and differentiation.

Authors:  Benjamin Uzan; Florence Figeac; Bernard Portha; Jamileh Movassat
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

10.  Cdk4 regulates recruitment of quiescent beta-cells and ductal epithelial progenitors to reconstitute beta-cell mass.

Authors:  Ji-Hyeon Lee; Junghyo Jo; Anandwardhan A Hardikar; Vipul Periwal; Sushil G Rane
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.